[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Melatonin 3 and 6 mg in icu admitted COVID-19 patients: Melatonin 3 mg to one group and 6 mg to other group in severe COVID-19 patients at 6pm every day till the patient is in icuControl Intervention1: Placebo is given to other half patients who are COVID-19 positive and admitted to icu: Placebo to COVID-19 patients in icu and checked for delirium.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Melatonin 3 and 6 mg in icu admitted COVID-19 patients: Melatonin 3 mg to one group and 6 mg to other group in severe COVID-19 patients at 6pm every day till the patient is in icu", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo is given to other half patients who are COVID-19 positive and admitted to icu: Placebo to COVID-19 patients in icu and checked for delirium.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "3 mg", "treatment_id": 779, "treatment_name": "Melatonin", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "6 mg", "treatment_id": 779, "treatment_name": "Melatonin", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]